Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CVS HealthCVS +2.12%75 EV-to-EBIT is 31.41 as of Jul. 29, 2026, which is 115% above its 10-year median of 14.61. GuruFocus rates CVS with a GF Score™ of 75/100 and a GF Value™ of $77.71 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 14 Healthcare Plans companies, CVS Health ranks worse than 78.57% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
CVS Health's Enterprise Value for the quarter that ended in Mar. 2026 was $158,151 Mil.
CVS Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $6,565 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVS Health EV-to-EBIT Related Terms
CVS Health EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for CVS Health's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, CVS Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CVS Health EV-to-EBIT vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, CVS Health's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where CVS Health's EV-to-EBIT falls into.
CVS Health's current Enterprise Value is $206,234 Mil.
CVS Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $6,565 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVS Health (CVS) has a EV-to-EBIT of 31.41 as of Jul. 29, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on CVS Health and its competitors. This is 115% above median its historical median of 14.61. Over the past decade, CVS Health's EV-to-EBIT has ranged from 9.15 to 36.07. According to the industry distribution chart, CVS Health ranks #11 out of 14 companies in the Healthcare Plans industry, placing it in the top 78.6%.
Is CVS Health's EV-to-EBIT too high?
CVS Health's current EV-to-EBIT of 31.41 is 115% above median its 10-year median of 14.61. Over the past 10 years, this metric has ranged from a low of 9.15 to a high of 36.07. The Healthcare Plans industry median EV-to-EBIT is 23.80. CVS Health's value of 31.41 is 32% above this industry median. Based on the distribution chart, CVS Health ranks #11 out of 14 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, CVS Health has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CVS Health's EV-to-EBIT compare to ELV and CI?
According to the Healthcare Plans industry distribution chart, CVS Health ranks #11 out of 14 companies for EV-to-EBIT. This places CVS Health in the lower half of its industry. The industry median EV-to-EBIT is 23.80. CVS Health's value of 31.41 is 32% above this benchmark. Historically, CVS Health's own EV-to-EBIT has ranged from 9.15 to 36.07 over the past decade. While the company's 10-year median is 14.61 vs. the industry median of 23.80, CVS Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Plans company?
The median EV-to-EBIT among Healthcare Plans companies is 23.80, based on 14 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CVS Health's current EV-to-EBIT of 31.41 is 32% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on CVS Health and its competitors. For the Healthcare Plans industry, the median EV-to-EBIT is 23.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CVS Health's current EV-to-EBIT is 31.41, which is 115% above median its own 10-year median of 14.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Health stock overvalued right now?
Based on GuruFocus' analysis, CVS Health (CVS) is currently considered Significantly Overvalued. The stock's GF Value™ is $77.71, compared to a current price of $109.34 — trading 40.7% above its estimated fair value. The current EV-to-EBIT is 31.41, which is 115% above median its 10-year median of 14.61 and 32% above the Healthcare Plans industry median of 23.80. CVS Health's overall GF Score™ is 75/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For CVS Health (CVS), the current EV-to-EBIT is 31.41 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CVS Health (CVS) Overvalued in 2026?
Based on GuruFocus' analysis, CVS Health stock appears to be overvalued.
The current stock price of $109.34 is trading 40.7% above its estimated GF Value™ of $77.71.
GuruFocus considers CVS Health to be Significantly Overvalued.
Key valuation signals for CVS:
EV-to-EBIT: 31.41 (115% above median its 10-year median of 14.61)
GF Value™: $77.71 vs. price of $109.34 (40.7% above fair value)
Industry Position: 32% above the Healthcare Plans median (#11 of 14)
No single metric tells the full story. See the CVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
75GF Score
Get the complete analysis for CVS
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVS has been successfully added to your 
